top of page
image.png

Patients are our priority, designing curative medicines is our mission

Our primary focus is patients suffering from currently incurable life altering diseases. The disruptive PRISM™ Platform is a leading-edge novel physics-based drug design engine that has resulted in a pipeline of clinic-ready assets for the treatment of diseases across multiple clinical areas including neurology, oncology, and infectious disease.

News & Press Releases

Therapeutic Focus Areas

NEUROLOGY

~3B

people living with neurological disease

POST-INFECTION

NEUROPATHOLOGY

100M

people affected by post-infection illness

85%

DRUG-INDUCED

NEUROPATHY

of chemo patients have dose-limiting neurotoxicity

1 in 6

INFECTIOUS DISEASES

deaths worldwide caused by infectious disease

bottom of page